Alyeska Investment Group
EQHA.U

Alyeska Investment Group’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Alyeska Investment Group’s Portfolio EQHA.U Stock Details EQHA.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,000
Closed -$396K – 954
2021
Q1 		$396K Buy
+40,000
New +$406K 0.01% 686

Other funds holding EQHA.U

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
IG
Inherent Group New York $108M AUM 55.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Alyeska Investment Group's EQHA.U Position: Q2 2021 in Review

Alyeska Investment Group sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q2 2021, closing a stake of 40,000 shares — an estimated $396K sold.

Alyeska Investment Group first reported a position in EQHA.U in Q1 2021 and held it in 1 quarter. The position peaked at $396K in Q1 2021. 43 funds tracked by Wall St. Rank hold EQHA.U as of Q2 2021.

  • Alyeska Investment Group reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 40,000 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q2 2021, an estimated $396K.
  • Alyeska Investment Group first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Alyeska Investment Group's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $396K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.